Labyrinth Psychiatry Group
Fostering Long-Term Mental Wellness through Personalized Care

Labyrinth Psychiatry Group helps patients free their lives from the shackles of mental health disorders through its full spectrum of psychiatric care.

The clinic provides a full range of services, including medication management, psychotherapy and advanced treatments like transcranial magnetic stimulation (TMS) and esketamine therapy. Before selecting a treatment, its efficient and courteous team of psychiatrists, nurse practitioners and therapists conducts thorough evaluations and screenings to identify the underlying issues that contribute to a patient’s symptoms.

“We don't assume our patients’ needs. We evaluate their symptoms and determine the appropriate treatment,” says Dr. Salvatore G. Savatta, MD.

Using a combination of evidence-based, FDA-approved treatments, Labyrinth Psychiatry Group treats depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD), attention-deficit hyperactivity disorder and obsessive-compulsive disorder.

Defeating Treatment-Resistant Depression with Esketamine

Labyrinth Psychiatry Group takes a thoughtful and measured approach to treatments. For example, it views esketamine as one tool in a broader arsenal of treatments rather than a cure-all. This nasal spray derivative of ketamine is a breakthrough in the treatment of severe, treatment-resistant depression.

The clinic leverages the medicine’s ability to target neurotransmitters in the brain differently than traditional antidepressants and treat patients who don’t show promising responses to other medications. It recommends esketamine therapy only to individuals after careful evaluation to ensure they will benefit.

Esketamine has been life-changing for many patients under Labyrinth Psychiatry Group’s care. In one instance, a woman who had been unable to work for two years due to depression greatly benefitted from the therapy and resumed work within two months of starting the treatment. She also found joy in her daily life–a transformation that had once seemed impossible.

The therapy also proved transformative for a woman who was suffering from severe PTSD and depressive disorder. She was treated with esketamine in combination with eye movement desensitization reprocessing and trauma-specific treatments. This led to her lasting recovery and restored her quality of life.

By focusing on outcomes rather than blindly following protocols, Labyrinth Psychiatry Group ensures that patients receive personalized care that adapts to their progress or deterioration of symptoms. The clinic discontinues treatment if patients don’t improve within two months and opts for alternatives. In cases where patients need additional assistance, it refers them to other specialty clinics.

Labyrinth Psychiatry group also takes a measured approach to leveraging TMS for treatment. It is a non-invasive treatment where magnetic pulses are delivered to stimulate nerve cells in the parts of the brain that controls mood. Repeated stimulation of this region of the brain, which is often underactive in patients with depression, produces an antidepressant effect.

Guaranteed Long-Term Care and Accessibility

One of the most significant challenges in mental health care is the affordability of treatments. Advanced therapies like TMS and esketamine, while incredibly effective, often come with a steep price tag, putting them out of reach for many patients. At Labyrinth Psychiatry Group, accessibility isn’t an afterthought—it’s a priority.

When esketamine first came to the market, patients paid thousands of dollars out-of-pocket for treatments. For most, this was a significant financial burden, even if the treatment could have dramatically improved their mental health. Labyrinth Psychiatry Group has relentlessly worked to ensure that its services are covered by insurance, breaking down the financial barriers that once stood between patients and the care they needed.

The clinic understands that accessibility is more about long-term support than money. While many clinics offer short-term interventions and send patients on their way, it takes a more comprehensive approach. Once a patient starts treatment, they’re not left to navigate the rest of their mental health journey alone. Regular follow-ups, medication management and ongoing counseling are all part of the package, guaranteeing that patients receive the continued care and guidance they need to sustain their progress.

It also extends the option of telehealth visits to save patients the time and effort of traveling to regular office visits for medication management and psychotherapy. This long-term care model is vital for patients with chronic or treatment-resistant conditions. After the initial treatment takes effect, patients are given the support they need to maintain their mental health and build habits that expedite their recovery.

The compassionate team of licensed mental health providers at Labyrinth Psychiatry Group is highly process-oriented. They are all adept at treating patients, but when uncertainties arise, they consult with Dr. Savatta, whose clinical practice is specifically tailored to treat treatment-resistant depression. A board-certified in adult psychiatry and forensic psychiatry, he has over two decades of work experience in numerous reputable medical centers, including Trinitas Regional Medical Center and New York Methodist Hospital.

Labyrinth Psychiatry Group is a practice built on the belief that mental health care should be as unique as the patients who seek it. From the first consultation to the long-term follow-up, every aspect of care is designed with the individual in mind. It doesn’t push treatments because they’re popular, and it doesn’t expect patients to navigate the complexities of mental health on their own.

By focusing on comprehensive evaluations and thoughtfully leveraging unconventional treatments like esketamine, Labyrinth Psychiatry Group is defining what patient-centered psychiatric care should look like.